EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Clinical and experimental aspects of tirbanibulin treatments

Annabel Shen, Rebecca A Simonette, Peter L Rady, Stephen K Tyring

Archives of Dermatological Research · 2025

DOI: 10.1007/s00403-025-04119-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Annabel Shen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The University of Texas McGovern Medical School, 6431 Fannin St, Houston, TX, 77070, USA. Hauptthemen laut MEDLINE: Skin Neoplasms, Keratosis, Actinic, Basal Cell Carcinoma, Carcinoma, Squamous Cell. Die Arbeit nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tirbanibulin is a topical medication approved in 2020 as a 5 day topical treatment for actinic keratosis, a precancerous skin lesion characterized by the hyperproliferation of atypical keratinocytes. Tirbanibulin exerts its effects through dual mechanisms: microtubule inhibition, which disrupts cell division, and Src kinase inhibition, which interferes with cancer-associated signaling pathways. Although its primary use is in AK, these mechanisms suggested potential therapeutic applications in a broader range of epithelial cancers. In this literature review, we explored tirbanibulin's application in not only actinic keratosis, but also in squamous cell carcinoma and basal cell carcinoma. We addressed the relevant findings obtained in recent papers to evaluate tirbanibulin's safety, efficacy, side effects, real-life clinical experiences, and its potential in anti-aging and skin lightening therapies on patients. In summary, we highlighted the preclinical and clinical evidence on the use of tirbanibulin as an effective and safe treatment option beyond AK. Graphical Abstract.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsKeratosis, ActinicBasal Cell CarcinomaCarcinoma, Squamous CellAntineoplastic AgentsHumansAnimalsSkin AgingKeratinocytes

Stichwörter der Autor:innen

Actinic keratosisMicrotubuleSCCSignaling pathwayTirbanibulin

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Dermatology, The University of Texas McGovern Medical School, 6431 Fannin St, Houston, TX, 77070, USA.
  • Department of Dermatology, The University of Texas McGovern Medical School, 6431 Fannin St, Houston, TX, 77070, USA. Stephen.K.Tyring@uth.tmc.edu.

Zitieren

APA

Shen, A., Simonette, R. A., Rady, P. L., & Tyring, S. K. (2025). Clinical and experimental aspects of tirbanibulin treatments. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-04119-9

Vancouver

Shen A, Simonette RA, Rady PL, Tyring SK. Clinical and experimental aspects of tirbanibulin treatments. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-04119-9

BibTeX
@article{Shen2025,
  author = {Shen, Annabel and Simonette, Rebecca A and Rady, Peter L and Tyring, Stephen K},
  title = {Clinical and experimental aspects of tirbanibulin treatments},
  journal = {Archives of Dermatological Research},
  year = {2025},
  doi = {10.1007/s00403-025-04119-9}
}
Kostenlos starten →